San Diego-centered Viking Therapeutics marked alone as a significant competitor within the weight loss drug sector in February right after revealing promising facts from a mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified being a weekly injection and in March the compan